Your browser doesn't support javascript.
loading
Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19.
Toor, Himanshu G; Banerjee, Devjani I; Lipsa Rath, Soumya; Darji, Siddhi A.
Afiliación
  • Toor HG; P.G. Department of Genetics, Ashok and Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences (ARIBAS), Charutar Vidya Mandal University, P.O. Box No. 61, New Vallabh Vidyanagar, Vitthal Udyognagar, 388121, Anand, Gujarat, India; Sardar Patel University, Gujarat,
  • Banerjee DI; Dr. Vikram Sarabhai Institute of Cell and Molecular Biology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Pratapganj, Vadodara, 390002, Gujarat, India. Electronic address: devjani.chak-cmb@msubaroda.ac.in.
  • Lipsa Rath S; National Institute of Technology, Warangal, Telangana, 506004, India. Electronic address: slrath@nitw.ac.in.
  • Darji SA; Dr. Vikram Sarabhai Institute of Cell and Molecular Biology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Pratapganj, Vadodara, 390002, Gujarat, India. Electronic address: siddhiadarji@gmail.com.
Eur J Pharmacol ; 890: 173720, 2021 Jan 05.
Article en En | MEDLINE | ID: mdl-33160938

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur J Pharmacol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur J Pharmacol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos